Research Analysts Set Expectations for XFOR FY2025 Earnings
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for X4 Pharmaceuticals in a research report issued to clients and investors on Tuesday, April 1st. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per share of ($0.35) for the year. […]
